Differences in adverse events between 250mg daily gefitinib and 150mg daily erlotinib in Japanese patients with non-small cell lung cancer

収録刊行物

  • Lung Cancer

    Lung Cancer 74 (1), 98-102, 2011-10

    Elsevier BV

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ